JUBILANT PHARMOVA
Back to Income Statement
|
JUBILANT PHARMOVA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹6,282 Cr | ₹6,130 Cr | ₹6,099 Cr | ₹5,976 Cr | ₹9,111 Cr |
What is the latest Revenue of JUBILANT PHARMOVA ?
Year | Revenue |
---|---|
Mar2024 | ₹6,282 Cr |
Mar2023 | ₹6,130 Cr |
Mar2022 | ₹6,099 Cr |
Mar2021 | ₹5,976 Cr |
Mar2020 | ₹9,111 Cr |
How is Revenue of JUBILANT PHARMOVA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹6,282 Cr | 2.47 | |
Mar2023 | ₹6,130 Cr | 0.52 | |
Mar2022 | ₹6,099 Cr | 2.05 | |
Mar2021 | ₹5,976 Cr | -34.41 | |
Mar2020 | ₹9,111 Cr | - |
Compare Revenue of peers of JUBILANT PHARMOVA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JUBILANT PHARMOVA | ₹19,124.0 Cr | 2.9% | 6.9% | 65.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,131.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
JUBILANT PHARMOVA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JUBILANT PHARMOVA | 2.9% |
6.9% |
65.4% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses